- Home
- KZIA vs HIHO Comparison
KZIA vs HIHO Comparison
Compare KZIA & HIHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- HIHO
- Stock Information
- Founded
- KZIA 1994
- HIHO 1990
- Country
- KZIA Australia
- HIHO Hong Kong
- Employees
- KZIA N/A
- HIHO N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- HIHO Industrial Machinery/Components
- Sector
- KZIA Health Care
- HIHO Industrials
- Exchange
- KZIA Nasdaq
- HIHO Nasdaq
- Market Cap
- KZIA 6.0M
- HIHO 8.2M
- IPO Year
- KZIA 1999
- HIHO 1996
- Fundamental
- Price
- KZIA $0.89
- HIHO $1.88
- Analyst Decision
- KZIA Strong Buy
- HIHO
- Analyst Count
- KZIA 2
- HIHO 0
- Target Price
- KZIA $11.50
- HIHO N/A
- AVG Volume (30 Days)
- KZIA 5.5M
- HIHO 4.0K
- Earning Date
- KZIA 03-26-2025
- HIHO 01-21-2025
- Dividend Yield
- KZIA N/A
- HIHO 6.39%
- EPS Growth
- KZIA N/A
- HIHO N/A
- EPS
- KZIA N/A
- HIHO N/A
- Revenue
- KZIA $1,655,324.00
- HIHO $7,345,000.00
- Revenue This Year
- KZIA $806.89
- HIHO N/A
- Revenue Next Year
- KZIA N/A
- HIHO N/A
- P/E Ratio
- KZIA N/A
- HIHO N/A
- Revenue Growth
- KZIA 248000.00
- HIHO 11.36
- 52 Week Low
- KZIA $0.89
- HIHO $1.70
- 52 Week High
- KZIA $15.80
- HIHO $2.88
- Technical
- Relative Strength Index (RSI)
- KZIA 28.96
- HIHO 48.27
- Support Level
- KZIA $0.90
- HIHO $1.83
- Resistance Level
- KZIA $1.60
- HIHO $1.94
- Average True Range (ATR)
- KZIA 0.24
- HIHO 0.04
- MACD
- KZIA 0.01
- HIHO 0.00
- Stochastic Oscillator
- KZIA 0.00
- HIHO 42.27
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About HIHO Highway Holdings Limited
Highway Holdings Ltd is a holding company. The company is a manufacturer of metal, plastic, electric and electronic components for original equipment manufacturers (OEM) and contract manufacturers. Its operating segment includes Metal stamping and mechanical OEM and Electric OEM. The metal stamping segment focuses on the manufacturing and sale of metal parts and components. The company generates maximum revenue from the Metal stamping and mechanical OEM segment. Geographically, it derives a majority of its revenue from Europe and also has a presence in Hong Kong and China, North America, and Other Asian countries.